ZEKE CAPITAL ADVISORS, LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 84 filers reported holding UROGEN PHARMA LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ZEKE CAPITAL ADVISORS, LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q1 2022$1,568,000
-72.2%
180,000
-69.7%
0.08%
-76.0%
Q4 2021$5,646,000
-53.6%
593,656
-18.0%
0.33%
-53.2%
Q3 2021$12,172,000
+10.3%
723,677
+0.1%
0.70%
+1.2%
Q2 2021$11,038,000
+9.6%
722,875
+39.8%
0.70%
-1.0%
Q1 2021$10,073,000517,1060.70%
Other shareholders
UROGEN PHARMA LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Horton Capital Management, LLC 684,749$11,517,00023.27%
GREAT POINT PARTNERS LLC 750,000$12,615,0002.94%
HealthInvest Partners AB 75,000$1,262,0001.89%
Wildcat Capital Management, LLC 533,139$8,967,0001.16%
Annandale Capital, LLC 86,254$1,451,0000.87%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$49,698,0000.73%
ZEKE CAPITAL ADVISORS, LLC 723,677$12,172,0000.70%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$426,0000.34%
RTW INVESTMENTS, LP 857,464$14,423,0000.22%
SHIKIAR ASSET MANAGEMENT INC 33,350$561,0000.16%
View complete list of UROGEN PHARMA LTD shareholders